The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury ; volume:11 ; number:1 ; day:11 ; month:5 ; year:2010 ; pages:1-10 ; date:12.2010
Trials ; 11, Heft 1 (11.5.2010), 1-10, 12.2010
- Creator
-
Bagshaw, Sean M.
- Contributor
- DOI
-
10.1186/1745-6215-11-50
- URN
-
urn:nbn:de:1111-2016050219109
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bagshaw, Sean M.
- Gibney, R T Noel
- McAlister, Finlay A.
- Bellomo, Rinaldo
- SpringerLink (Online service)
Other Objects (12)
Acute renal failure in the critically ill : with 27 tables
Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”
Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
The obesity paradox and hypoglycemia in critically ill patients
Hemoperfusion: technical aspects and state of the art
Impact of Intensity of Continuous Renal Replacement Therapy on Duration of Ventilation in Critically Ill Patients: A Secondary Analysis of the RENAL Trial
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
Fever in sepsis: is it cool to be hot?
Continuous beta-lactam infusion in critically ill patients: the clinical evidence
Correction to: Is the literature inconclusive about the harm from HES? No
Acute renal failure in the critically ill : with 27 tables
Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”
Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
The obesity paradox and hypoglycemia in critically ill patients
Hemoperfusion: technical aspects and state of the art
Impact of Intensity of Continuous Renal Replacement Therapy on Duration of Ventilation in Critically Ill Patients: A Secondary Analysis of the RENAL Trial
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
Fever in sepsis: is it cool to be hot?
Continuous beta-lactam infusion in critically ill patients: the clinical evidence
Correction to: Is the literature inconclusive about the harm from HES? No
Acute renal failure in the critically ill : with 27 tables
Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”
Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
The obesity paradox and hypoglycemia in critically ill patients
Hemoperfusion: technical aspects and state of the art
Impact of Intensity of Continuous Renal Replacement Therapy on Duration of Ventilation in Critically Ill Patients: A Secondary Analysis of the RENAL Trial
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply
The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation
Fever in sepsis: is it cool to be hot?
Continuous beta-lactam infusion in critically ill patients: the clinical evidence